Permanent HBP was feasible and safe in a large real-world population requiring permanent pacemakers. His bundle pacing was associated with reduction in the combined endpoint of death, HFH, or upgrade to BiVP compared to RVP in patients requiring permanent pacemakers.

Layered double hydroxides (LDHs) are currently attracting intense research interest for their various applications. Three LDH hollow nano-polyhedra are synthesized with zeolitic imidazolate framework-67 (ZIF-67) nanocrystals as the templates. The nanocages well inherit the rhombic dodecahedral shape of the ZIF-67 templates, and the shell is composed of nanosheets assembled with an edge-to-face stacking. This is the first synthesis of the LDH non-spherical structures. And the mechanism of utilizing metal-organic framework (MOF) nanocrystals as templates is explored. Control of the simultaneous reactions, the precipitation of the shells and the template etching, is extremely crucial to the preparation of the perfect nanocages. And the Ni-Co LDH nanocages exhibit superior pseudocapacitance property due to their novel hierarchical and submicroscopic structures.

Truncated rhombic dodecahedral zeolitic imidazolate framework-8 (ZIF-8) nanocrystals are fabricated with acetate as a modulating ligand; ZnS hollow polyhedra with uniform morphology are obtained using the ZIF-8 templates.

A solvothermal process was designed to synthesize magnetite (Fe 3 O 4 ) nanorods using iron pentacarbonyl (Fe(CO) 5 ), oleic acid, and hexadecylamine as raw materials. In the preparation process, Fe(CO) 5 was first decomposed and oxidized to form FeO. Meanwhile, Fe(CO) 5 reacted with oleic acid to form iron oleate. In the system water derived from the reaction between oleic acid and hexadecylamine resulted in the hydrolysis of iron oleate to form the initial Fe 3 O 4 nanorods. In the following process, the dissolution of FeO and decomposition of residual Fe(CO) 5 as well as the hydrolysis of iron oleate provided the source for the growth of Fe 3 O 4 nanorods, which led to the enlargement of the particles with time. By adjusting the reaction time or the amount of the added hexadecylamine, the length of uniform nanorods could be tuned from 63 to 140 nm. Furthermore, the as-prepared Fe 3 O 4 nanorods showed excellent performance in electrochemical property and exhibited different magnetic property from spherical nanoparticles and nanoplates for their shape anisotropy.

BackgroundStudies of the difference between menstrually associated and non-menstrually associated migraine are somewhat controversial. The majority of studies have focused on comparing menstrual to non-menstrual attacks rather than comparing study groups with different migraine diagnoses with respect to menstruation. As there is limited knowledge available on the overall impact and burden of migraine among groups of women with and without menstrually associated migraine our goal was to examine differences between these groups. We hypothesized that there would be greater burden of migraine related to menstruation and headache frequency in a population study across groups of women.MethodsWe analyzed data from the American Migraine Prevalence and Prevention (AMPP) Study, a longitudinal, US, population-based study. We included female respondents to the 2009 survey, aged 18 to 60, who met modified ICHD-2 criteria for migraine, were actively menstruating and fit one of three definitions based on the self-reported association of menses and migraine attacks: self-reported predominantly menstrual migraine (MM, attacks that only or predominantly occur at the time of menses), self-reported menstrually-associated migraine (MAM, attacks commonly associated with menses, but that also occur at other times of the month), and self-reported menstrually-unrelated migraine (MUM). These three groups were compared on characteristics and measures of headache impact and burden (Headache Impact Test– 6 item (HIT-6) and Migraine Disability Assessment Scale (MIDAS).ResultsThere were 1,697 eligible subjects for this study in the following categories: MM (5.5%), MAM (53.8%), or MUM (40.7%). Women with MM had an older age of migraine onset. Those with predominantly menstrually-related attacks (MM) had fewer headache-days but appeared to be more impaired by attacks. HIT-6 and MIDAS scores were significantly higher for both the MM and MAM groups compared with the MUM groups; however, effects were more robust for MM than MAM.ConclusionsNearly 60% of women with migraine reported an association between migraine and menses. These women reported greater headache impact and migraine-related burden on functioning than those in whom migraines were not related to menstruation. Women with MM were more impaired by attacks while women with MAM had overall highest burden, likely due to experiencing migraines on additional days.